Market Cap ₹377 Cr.
Stock P/E 9.5
P/B 0.6
Current Price ₹198.5
Book Value ₹ 339.1
Face Value 10
52W High ₹264.5
Dividend Yield 1.01%
52W Low ₹ 141.1
Nath Bio-Genes (India) Ltd engages inside the production, processing, and advertising of hybrid and GM seeds in India and the world over. It operates in segments, Agricultural Activities and Trading Activities. The company gives seeds for cereals, which include maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, consisting of cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green peas, pumpkin, tinda, cabbage, and French beans. It also gives crop protection supplements, along with WINPro GOLii, WINall, and Win Chi Win boom enhancer; and forage supplements, consisting of NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The organisation offers its merchandise through a network of distributors, sellers, and processing plants. Nath Bio-Genes (India) Ltd became founded in 1979 and is primarily based in Aurangabad, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 25 | 45 | 235 | 23 | 32 | 43 | 244 | 32 | 37 | 52 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Total Income | 25 | 45 | 235 | 23 | 32 | 43 | 244 | 32 | 37 | 56 |
| Total Expenditure | 20 | 41 | 198 | 18 | 26 | 39 | 207 | 27 | 29 | 52 |
| Operating Profit | 6 | 4 | 37 | 5 | 6 | 4 | 37 | 5 | 9 | 4 |
| Interest | 3 | 2 | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 2 | 33 | 2 | 5 | 2 | 34 | 1 | 4 | 2 |
| Provision for Tax | 1 | 0 | 0 | 0 | 1 | 1 | 0 | -0 | 1 | 1 |
| Profit After Tax | 1 | 1 | 33 | 2 | 4 | 2 | 33 | 1 | 3 | 1 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 1 | 0 | -0 | 0 | 1 |
| Profit After Adjustments | 1 | 1 | 33 | 2 | 4 | 3 | 33 | 1 | 3 | 1 |
| Adjusted Earnings Per Share | 0.7 | 0.8 | 17.5 | 0.8 | 2 | 1.4 | 17.6 | 0.6 | 1.4 | 0.8 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 124 | 138 | 278 | 301 | 333 | 365 |
| Other Income | 1 | 1 | 2 | 1 | 1 | 4 |
| Total Income | 125 | 138 | 280 | 302 | 333 | 369 |
| Total Expenditure | 109 | 118 | 241 | 252 | 283 | 315 |
| Operating Profit | 16 | 20 | 39 | 50 | 51 | 55 |
| Interest | 2 | 4 | 11 | 10 | 9 | 10 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | -89 | 0 | 3 | 0 |
| Profit Before Tax | 9 | 12 | -63 | 36 | 42 | 41 |
| Provision for Tax | -0 | 1 | 4 | 1 | 2 | 2 |
| Profit After Tax | 9 | 12 | -67 | 35 | 40 | 38 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit After Adjustments | 9 | 12 | -67 | 35 | 40 | 38 |
| Adjusted Earnings Per Share | 0 | 0 | -35.5 | 18.4 | 20.8 | 20.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 34% | 0% | 0% |
| Operating Profit CAGR | 2% | 37% | 0% | 0% |
| PAT CAGR | 14% | 49% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -5% | 9% | -10% | 7% |
| ROE Average | 7% | -3% | 7% | 7% |
| ROCE Average | 7% | -0% | 9% | 9% |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Shareholder's Funds | 46 | 57 | 542 | 573 | 610 |
| Minority's Interest | 0 | 0 | -0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 0 | 5 |
| Other Non-Current Liabilities | 1 | 1 | 3 | 3 | 3 |
| Total Current Liabilities | 72 | 98 | 194 | 216 | 262 |
| Total Liabilities | 119 | 157 | 739 | 793 | 880 |
| Fixed Assets | 21 | 38 | 245 | 244 | 249 |
| Other Non-Current Assets | 2 | 0 | 27 | 29 | 59 |
| Total Current Assets | 96 | 120 | 468 | 520 | 572 |
| Total Assets | 119 | 157 | 739 | 793 | 880 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 3 | 29 | 4 | 38 |
| Cash Flow from Operating Activities | 0 | 14 | 17 | 38 | 75 |
| Cash Flow from Investing Activities | 0 | -21 | -20 | -3 | -27 |
| Cash Flow from Financing Activities | 0 | 6 | -22 | -2 | -8 |
| Net Cash Inflow / Outflow | 0 | -1 | -25 | 34 | 39 |
| Closing Cash & Cash Equivalent | 0 | 2 | 4 | 38 | 77 |
| # | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | -35.46 | 18.43 | 20.85 |
| CEPS(Rs) | 8.69 | 10.16 | -33.84 | 20.01 | 22.56 |
| DPS(Rs) | 0 | 0 | 2 | 2 | 2 |
| Book NAV/Share(Rs) | 0 | 0 | 285.16 | 301.61 | 320.94 |
| Core EBITDA Margin(%) | 11.84 | 14.45 | 13.37 | 16.25 | 15.02 |
| EBIT Margin(%) | 8.78 | 11.6 | -18.96 | 15.44 | 15.26 |
| Pre Tax Margin(%) | 7.32 | 8.93 | -22.79 | 12 | 12.5 |
| PAT Margin (%) | 7.42 | 8.53 | -24.21 | 11.62 | 11.91 |
| Cash Profit Margin (%) | 11.22 | 11.8 | -23.1 | 12.62 | 12.89 |
| ROA(%) | 7.73 | 8.5 | -15.03 | 4.57 | 4.74 |
| ROE(%) | 20.12 | 22.76 | -22.48 | 6.28 | 6.7 |
| ROCE(%) | 19.09 | 23.88 | -14.84 | 7.09 | 7.26 |
| Receivable days | 36.68 | 44.32 | 69.85 | 110.74 | 105.14 |
| Inventory Days | 193.69 | 189.43 | 195.06 | 259.3 | 240.4 |
| Payable days | 1576.65 | -4219.16 | 1503.38 | 744.29 | -1457.17 |
| PER(x) | 0 | 0 | 0 | 7.69 | 8.33 |
| Price/Book(x) | 0 | 0 | 0.75 | 0.47 | 0.54 |
| Dividend Yield(%) | 0 | 0 | 0.94 | 1.41 | 1.15 |
| EV/Net Sales(x) | 0.19 | 0.24 | 1.78 | 1.12 | 1.09 |
| EV/Core EBITDA(x) | 1.54 | 1.6 | 12.65 | 6.79 | 7.18 |
| Net Sales Growth(%) | 0 | 11.13 | 102.15 | 8.26 | 10.37 |
| EBIT Growth(%) | 0 | 46.76 | -430.58 | 188.13 | 9.13 |
| PAT Growth(%) | 0 | 27.66 | -673.7 | 151.96 | 13.16 |
| EPS Growth(%) | 0 | 0 | -583.1 | 151.98 | 13.11 |
| Debt/Equity(x) | 0.25 | 0.33 | 0.17 | 0.18 | 0.18 |
| Current Ratio(x) | 1.34 | 1.22 | 2.41 | 2.4 | 2.18 |
| Quick Ratio(x) | 0.42 | 0.43 | 1.27 | 1.44 | 1.3 |
| Interest Cover(x) | 6.02 | 4.35 | -4.96 | 4.49 | 5.52 |
| Total Debt/Mcap(x) | 0 | 0 | 0.23 | 0.39 | 0.33 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 |
| FII | 0.15 | 0.13 | 0.07 | 0.22 | 0.32 | 0.27 | 0.21 | 0.18 | 0.19 | 0.21 |
| DII | 4.62 | 4.62 | 4.62 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 3.95 |
| Public | 49.63 | 49.65 | 49.71 | 49.81 | 49.72 | 49.76 | 49.82 | 49.85 | 49.84 | 50.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
| FII | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| DII | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Public | 0.94 | 0.94 | 0.94 | 0.95 | 0.94 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
